Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)

Market Cap	12.80B +314.1%
Revenue (ttm)	604.86M +2.2%
Net Income	50.65M -37.4%
EPS	0.31 -34.9%
Shares Out	161.23M
PE Ratio	256.96
Forward PE	151.18
Dividend	0.15 (0.19%)
Ex-Dividend Date	Jul 14, 2025

Volume	4,829,360
Average Volume	7,680,818
Open	85.61
Previous Close	86.31
Day's Range	81.78 - 86.31
52-Week Range	16.55 - 89.77
Beta	0.85
RSI	57.43
Earnings Date	Apr 24, 2026

About SHE:301093

Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. engages in the research and development, manufacture, and sale of packaging materials for the pharmaceuticals' industry in China and internationally. It offers covered rubber stoppers series; halogenated butyl rubber stopper freeze-dryied series; halogenated butyl rubber stopper antibiotics series; halogenated butyl rubber plugs infusion series; combination cap series for plastic infusion vessels; polyisoprene gaskets; blood plugs; halogenated butyl rubber stopper for oral dosage forms; pre-po...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1992
• Employees: 930
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301093

Financial Performance

In 2024, SHE:301093's revenue was 586.41 million, a decrease of -5.86% compared to the previous year's 622.92 million. Earnings were 49.57 million, a decrease of -57.96%.